ArticleClinical and translational allergy2026
Insights into Api m 10-Isoforms and Splice Variants: More Than One Major IgE-Binding Epitope.
Article in Clinical and translational allergy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Insights into Api m 10-Isoforms and Splice Variants: More Than One Major IgE-Binding Epitope.Clinical and translational allergy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHoney bee venom (HBV) often triggers severe IgE-mediated allergies. The major allergen icarapin (Api m 10) has attracted attention due to low occurrence in some HBV immunotherapy products. Despite being a major allergen, little is known about the Api m 10 structure and IgE-binding regions. This study aimed to characterize its IgE-binding epitopes and structure in more detail.
methodsOverlapping Api m 10-specific peptides covering the sequences of the 11 known Api m 10-isoforms and variants were synthesized and spotted on microarray slides (15 amino acids (AA), off-set: 4 AA). Sera from 28 HBV-allergic patients with detectable Api m 10-specific IgE were used to characterize the distinct IgE-binding profiles to all Api m 10-variants. Sera from ten Api m 10-immunized BALB/c mice were used to investigate possible shared epitopes between humans and mice. All Api m 10-variants were investigated for secondary structural elements via circular dichroism spectroscopy and potential aggregation via dynamic light scattering.
resultsWe identified 7 different linear IgE-binding motifs. All 28 patients' sera displayed IgE-binding to one specific area (present in Api m 10-isoforms 1 and 2 and putative splice variants 3, 4, 6), indicating a major IgE-epitope. IgE-inhibition provided evidence that the major epitope makes up less than 50% of the total IgE-binding capacity, suggesting that additional (most likely conformational) IgE-epitopes play an important role in Api m 10-sensitization. Api m 10-specific murine IgG and human IgE both predominantly bind to seven different AA-motifs, of which six are identical between both species. Api m 10-isoforms 1 and 2 displayed secondary structural elements and appeared to be aggregated.
conclusionThe structural, clinical and preclinical insights into Api m 10 and its immunodominant epitopes gained in this study provide substantial insights for the future development of active and passive VIT as well as further treatment approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.